Obstrüktif Uyku Apne Sendromuna Sahip Türk Hastalarda Vitamin D Reseptör Polimorfizmlerinin İncelenmesi

Objective: Numerous studies investigating Vitamin D receptor (VDR) polymorphisms in different populations have been present in current literature. For this reason, we designed a study to investigate the role of three known common VDR genetic polymorphisms (Apa-I/rs7975232, Bsm-I/ rs1544410 and Taq-I/rs731236) in Turkish individuals affected by Obstructive sleep apnea syndrome (OSAS). Methods: The study was carried out on a total of 175 consecutive subjects, including 80 OSAS patients and 95 healthy participants. Single Nucleotide Polymorphism (SNP) Detection was performed with the iPLEX® Assay and the MassARRAY® System for detection of Apa-I (rs7975232), Bsm-I (rs1544410), and Taq-I (rs731236) polymorphisms. Results: Fifty-seven C alleles (71.3%) and 59 T alleles (73.8%) were detected in the group of 80 OSAS patients in terms of rs1544410 polymorphism. When the patient and control groups were evaluated statistically at allelic level, it was observed that the T allele increased the risk of disease and this increase was statistically significant (Odds Ratio (OR) = 1.549 [Confidence Interval (CI): 1.012-2.371], (p=0.043). However, there were no significant differences between other VDR polymorphisms (rs7975232 and rs731236) and OSAS clinical data (p=0.6 and p=0.9, respectively). Discussion: As a conclusion, no statistically significant relationship was found between all three VDR polymorphisms and OSAS patients' clinical features. Further studies should be performed by creating a large sampling group. Finally, population studies should be given importance considering the variability of polymorphism according to ethnic origin.

Anahtar Kelimeler:

Obstructive sleep apnea syndrome, Apnea-hypopnea index

Evaluation of Mental and Behavioral Disorders in Patients Who Have Applied to the Disability Board of a District State Hospital in Diyarbakir

Objective: Although disability is a major problem in our country, there are few studies on this subject. The aim of this study was to determine the demographic characteristics and the prevalence of psychiatric diagnoses of people with a disability board report from a district state hospital serving rural areas. Method: The files of 3842 people who applied to a district state hospital’s disability board between September 2016 and February 2019 were retrospectively investigated. Demographic information, diagnoses and disability rates of 576 individuals who were given a psychiatric disability rate were examined. Results: Of the individuals who had been given a psychiatric diagnosis and disability rate, 312 were male (54.2%), 264 of them were female (45.8%), and the mean age was 42.6±17.4. The mean total disability rate was 62.7±20.9% and the rate of disability related to psychiatry was 42.5±22.5%. The number of people who were decided by the disability board to be severely disabled since they could not perform their daily activities without the help of others was 96 (0.2%). The first five psychiatric diagnoses with the highest rate of disability were schizophrenia- treatment resistant (17.4%), generalized anxiety disorder- partial response (17.4%), mild mental retardation (IQ:50-69) (12.5%), borderline mental capacity (IQ: 70-80) (11.7%) and dysthymia- partial response (8.7%). Conclusions: Our study revealed that the most common causes of psychiatric disability are schizophrenia and generalized anxiety disorder. This study may be useful in revealing the situation of mentally and behaviorally disabled people in our country and may also serve as a guide in making arrangements regarding these people.

Keywords:

Disability Board, Severely Disabled, Schizophrenia Generalized Anxiety Disorder, Mental Retardation,

PDF

___

1. Peppard PE, Young T, Barnet JH, et al. Increased prevalence of sleep-disordered breathing in adults. Am J Epidemiol. 2013; 177: 1006-14.
2. Ragia G, Archontogeorgis K, Simmaco M, et al. Genetics of Obstructive Sleep Apnea: Vitamin D Receptor Gene Variation Affects Both Vitamin D Serum Concentration and Disease Susceptibility. OMICS. 2019; 23: 45-53.
3. Archontogeorgis K, Nena E, Papanas N, et al. Biomarkers to improve diagnosis and monitoring of obstructive sleep apnea syndrome: current status and future perspectives. Pulm Med. 2014; 2014: 930535.
4. Archontogeorgis K, Nena E, Papanas N, et al. The role of vitamin D in obstructive sleep apnoea syndrome. Breathe (Sheff). 2018; 14: 206-15.
5. Punjabi NM. The epidemiology of adult obstructive sleep apnea. Proc Am Thorac Soc. 2008; 5: 136-43.
6. Redline S, Tishler PV. The genetics of sleep apnea. Sleep Med Rev. 2000; 4: 583-602.
7. Palmer LJ, Buxbaum SG, Larkin E, et al. A wholegenome scan for obstructive sleep apnea and obesity. Am J Hum Genet. 2003; 72: 340-50.
8. Strohl KP, Redline S. Recognition of obstructive sleep apnea. Am J Respir Crit Care Med. 1996; 154 (2 Pt 1): 279-89.
9. Neighbors CLP, Noller MW, Song SA, et al. Vitamin D and obstructive sleep apnea: a systematic review and meta-analysis. Sleep Med. 2018; 43: 100-8.
10. Fernandes de Abreu DA, Eyles D, Feron F. Vitamin D, a neuro-immunomodulator: implications for neurodegenerative and autoimmune diseases. Psychoneuroendocrinology. 2009; 34 Suppl 1: S265-77.
11. Haussler MR, Whitfield GK, Kaneko I, et al. Molecular mechanisms of vitamin D action. Calcif Tissue Int. 2013; 92: 77-98.
12. Uitterlinden AG, Fang Y, Van Meurs JB, et all. Genetics and biology of vitamin D receptor polymorphisms. Gene. 2004; 338: 143-56.
13. Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep. 1991; 14: 540-5.
14. Ruehland WR, Rochford PD, O'Donoghue FJ, et al. The new AASM criteria for scoring hypopneas: impact on the apnea hypopnea index. Sleep. 2009; 32: 150-7.
15. Sasieni PD. From genotypes to genes: doubling the sample size. Biometrics. 1997; 53: 1253-61.
16. Alizadeh S, Djafarian K, Alizadeh H, et al. Common Variants of Vitamin D Receptor Gene Polymorphisms and Susceptibility to Coronary Artery Disease: A Systematic Review and Meta-Analysis. J Nutrigenet Nutrigenomics. 2017; 10: 9-18.
17. Yu F, Cui LL, Li X, et al. The genetic polymorphisms in vitamin D receptor and the risk of type 2 diabetes mellitus: an updated meta-analysis. Asia Pac J Clin Nutr. 2016; 25: 614-24.
18. Wang L, Ma J, Manson JE, et al. A prospective study of plasma vitamin D metabolites, vitamin D receptor gene polymorphisms, and risk of hypertension in men. Eur J Nutr. 2013; 52: 1771-9.